A pair of black gloves recovered near Nancy Guthrie’s Tucson-area home is being tested for DNA, marking the latest development in the investigation into her disappearance. Authorities said the gloves ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

Testing period blood for signs of cervical cancer could be an accurate and convenient way of screening for the disease, researchers say. The current NHS test involves a nurse or doctor taking a sample ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...

After decades of uncertainty, a long-dismissed illness may finally be leaving a measurable trace in blood. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affects but has always been ...

CLEVELAND — Last August, Kristin Gype was 38 weeks pregnant with her second child, expecting a smooth delivery. But during a routine checkup, something unusual appeared on the ultrasound: Her amniotic ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

Beyond the myriad complications that come with diabetes, patients have to additionally put up with regular blood sugar testing – which involves either multiple pin pricks a day to draw blood or ...

A San Diego medical technology company received FDA clearance this morning for a device that could transform how patients get blood tests done. The FDA cleared Truvian's new TruVerus machine, which ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...